Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Garetosmab

Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women

Regeneron · Phase 1 · Withdrawn · Enrollment 0

NCT06970405

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
High Dosen/rn/rn/rn/r
Low Dosen/rn/rn/rn/r
Placebon/rn/rn/rn/r

Not shown

  • High Dose: endpoint not reported
  • Low Dose: endpoint not reported
  • Placebo: endpoint not reported